Señales en vivo de OPORF | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 abr 2024 @ 13:26):

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials...

Stats
Volumen de hoy	72 750.00
Volumen promedio	40.00
Capitalización de mercado	238.13M
EPS	$0 ( 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	11.67
ATR14	$0.00700 (2.00%)

Volumen Correlación

Largo: 0.25 (neutral)

Corto: 0.49 (neutral)

Signal:(93.102) Neutral

hVIVO plc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

hVIVO plc Correlación - Moneda/Commodity

0.77
( moderate )

0.64
( weak )

0.00
( neutral )

0.43
( neutral )

-0.35
( neutral )

-0.81
( strong negative )

hVIVO plc Finanzas

Annual	2023
Ingresos:	$56.04M
Beneficio Bruto:	$7.70M (13.74 %)
EPS:	$0.0238

FY	2023
Ingresos:	$56.04M
Beneficio Bruto:	$7.70M (13.74 %)
EPS:	$0.0238

FY	2022
Ingresos:	$48.48M
Beneficio Bruto:	$4.00M (8.26 %)
EPS:	$-0.00120

Financial Reports:

No articles found.

hVIVO plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

hVIVO plc

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.